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Today's health care economy requires that methods be found
to maintain the quality of patient care while assuring the
availability of costly new therapeutic devices within the
constraints of an increasingly limited budget. Reuse of car-
diac pacemaker pulse generators may be one way to help
achieve this objective by allowing maximal utilization of
such long-lived medical devices.
A recent survey of the North American Society of Pacing
and Electrophysiology (NASPE) membership by Hauser (1)
has shown that present cost-cutting measures instituted by
hospitals across the United States in response to prospective
payment systems (DRGs) are resulting in important changes
in pacemaker implantation practices. This survey revealed
that 45% of respondents were implanting less expensive
pacemakers and 41% had adopted stricter criteria for se-
lecting dual-chamber pacemakers. Thirty-eight percent
avoided "nonessential features" in the pulse generators,
32% used a limited number of models and 27% indicated
that they implanted fewer pulse generators altogether. Some
small community hospitals and large teaching medical cen-
ters have been forced to curtail or discontinue pacemaker
implantation (Boal BH, personal communication). Such trends
already may have compromised the quality of medical care
being provided to patients who require implantation of car-
diac pacemakers.
To address these issues, a NASPE Policy Conference
was held on September 21, 1984 to study the feasibility of
reusing cardiac pacemakers that are still reliable and have
many years of useful life remaining. The proceedings of
this conference are being published elsewhere (2) and pro-
vide the necessary background for the conclusions presented
here.
*The Policy Conference, sponsored by the North American Society of
Pacing and Electrophysiology, 13 Eaton Court, Wellesley Hills, Massa-
chusetts 02181, was held on September 21,1984 in Queens, New York.
This report is being published simultaneously in PACE.
Address for reprints: Bernard H. Boal, MD, Booth Memorial Medical
Center, Main Street at Booth Memorial Avenue, Flushing, New York
11355.
Experience with reutilization of cardiac pace-
makers. Since 1978, there have been reports (3-8) from
many parts of the world of safe and effective reuse of cardiac
pacemakers after simple in-house cleansing, testing and ster-
ilization. These data describe the efficacious reuse of almost
2,000 cardiac pacemakers and confirm the absence of mor-
tality and increased morbidity caused by infection, rejection
and hepatitis attributable to pacemaker reutilization. In this
entire experience, there has been only one instance (9) of
premature pulse generator failure (< O. I% incidence) which
could be attributable to reuse. This incidence compares fa-
vorably with past experience with new cardiac pacemakers.
It should be noted that it is current medical practice to reuse
other medical devices, such as renal dialyzers (10) or Sones
and multi-electrode catheters, that were intended originally
for single use. Previous economic circumstances led to dis-
posal of such medical devices after single use because at
that time and in those specific instances, it was less costly
than cleansing and resterilization. Current economic realities
justify consideration of the reuse of many of these "single-
use" medical devices, including cardiac pacemakers.
The reutilization of cardiac pacemakers is fiscally sound.
In a 1980 report from Melbourne, Australia, Mond et al.
(4) estimated that because of the negligible cost of in-house
refurbishing, almost the entire cost of each reused implanted
pulse generator could be saved. This conclusion has been
reinforced by reports from several other centers as well
(5-7). It is clear that the cost of preparing a pulse generator
in a hospital is only a small fraction of the cost of a com-
parable new pulse generator. The cost of having pulse gen-
erators refurbished by an independent agency or original
manufacturer may differ.
Thus, the world experience indicates that the reuse of
cardiac pulse generators is medically efficacious and safe if
they are properly cleansed, sterilized, reliably tested for
function and battery life and the use of the particular pulse
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generator is individualized to a patient's needs as is the
current practice with the variety of new pacemakers that are
available. If these requirements are met, it is accepted that
there are no medical contraindications to the interchangeable
use of new or previously implanted pulse generators. To
assess on an ongoing basis the results of such potential reuse
of implantable pulse generators in the United States, the
establishment of a registry of such devices is essential.
Suggested changes in regulations and legal policy.
There are major constraints to pacemaker reuse, particularly
the reluctance of a physician to recommend and the patient
to accept a "second-hand" device, and the danger to the
physician, hospital and manufacturer of legal liability in the
event of device malfunction. Several changes in regulations
(and eventually in perception) are recommended that may
modify or obviate these objections.
Ownership of the pacemaker should be redefined. The
pacemaker should be in the exclusive custody of the patient
during that patient's need, then should become available for
reuse when it has been explanted for any reason. Each
candidate for a reused pacemaker must be informed that it
has been used previously and also be informed of the risks,
benefits, alternatives and possible incentives attached to ac-
ceptance of a previously used device. A conventional man-
ufacturer's warranty should end with a second use unless
otherwise stated. Nevertheless, the responsibility for quality
of design and manufacture should continue with the man-
ufacturer throughout the lifetime of the pacemaker.
The implantation of a previously used pacemaker should
not be considered substandard care. Physicians should be
allowed to reuse pacemakers in an individual practice under
their sole responsibility in accordance with methods for
evaluation and preparation of the pulse generator described
later in this report. Hospitals should establish protocols for
the intrahospital reuse of pulse generators by members of
their medical staff within their institutional guildelines. In
such cases of intrahospital reuse, the physicians who provide
the subsequent use need not be the original implanters. The
procedures described in this paragraph should be considered
"physician practice" and, therefore, are not subject to reg-
ulation by the Food and Drug Administration. In such cases,
the responsibility for knowledge of changes in pacemaker
status after reuse belongs to the reusing physician or the
institution. Reregistration with the manufacturer after im-
plantation will ensure that the appropriate physician can be
notified in the event of such a change in status. Once a
pacemaker intended for reuse goes beyond the individual
physician or institutional boundaries, it should be regulated
as a manufactured product by the Food and Drug Admin-
istration. Necessary laws, regulations and policies should
be developed to implement all of these recommendations.
Recommended guidelines for in-hospital recondition-
ing of pacemakers. With the understanding that reutili-
zation will never be possible unless the legal issues have
been resolved first, the following are guidelines recom-
mended for in-hospital reconditioning only, with the antic-
ipation that should reconditioning be done by the manufac-
turer or some other agency, it will be under their own
individual standards and guidelines.
Any lithium or nuclear powered pulse generator should
be considered acceptable for reuse except for the following:
I) any model with a questionable history, such as one that
has been subject to recall or one with an actuarial survival
at I year of less than 98% with confidence limits of 5%
(data for pulse generator survival can be acquired from an
independent national registry); 2) any pulse generator for
which insufficient information is available from the man-
ufacturer on which the interpretation of test results may be
based (for example, battery impedance and normal direct
current capacitor leakage); 3) any pulse generator whose
postexplantation history cannot be documented by the re-
sponsible physician; 4) any pulse generator with significant
physical defects of the case or the header; 5) any pulse
generator explanted from a patient who was subjected to
therapeutic ionizing radiation or defibrillatory shocks; and
6) any pulse generator in which the projected remaining
useful lifetime is less than 5 years at nominal operating
parameter settings.
In evaluating an explanted pulse generator for possible
reuse, the specific tests to be performed will depend on the
model being reprocessed. All appropriate noninvasive tests
should be performed that might reasonably be expected to
expose a defect. These include but are not limited to esti-
mation of the residual useful battery capacity and assessment
of device performance related to output, sensing, timing and
logic, programmability and telemetry. The pulse generator
should be subjected to vibration tests for the detection of
potential intermittent mechanical problems.
Cleansing and sterilization are of utmost importance. Im-
mediately after explantation, the pulse generator should be
washed to remove blood and tissue debris. All movable
parts, such as setscrews, plugs and a-rings, should be re-
moved. After this washing, the unit should be soaked in an
antiseptic solution. It should then undergo physical cleans-
ing with detergents and other agents such as formaldehyde
or gluteraldehyde. Finally, it should be packaged and ster-
ilized, preferably with ethylene oxide according to accepted
hospital protocol. All tests, cleansing and sterilization must
be performed according to written protocols by skilled per-
sonnel who are trained in the appropriate techniques. Thor-
ough records must be kept, with copies of these records
placed on the patient's chart and in a central file.
In summary, this report supports the concept that the
reuse of selected cardiac pulse generators is medically safe
and efficacious. It is estimated that 20% or more of im-
planted pacemakers could be reused if this policy were adopted
(4-8). It is urged that legal and technical criteria be estab-
lished to remove the impediments to the adoption of this
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practice as a means of improving the cost-efficiency of the
health care delivery system and reversing trends and prac-
tices that may compromise the quality of medical care.
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